|
|
|
|
| Showcasing state-of-the-art facilities and cutting-edge equipment driving the API manufacturing process - Outsourced Pharma Capacity Update’s new PARTNER WEEK offers an extended schedule grouped by capability including a new Small Molecule API & HPAPI Development session. Register today for this digital event happening May 22nd. |
|
|
|
|
By Ray Knox, KBDG | We encounter the term “the end in mind” in product development frequently, but many are unsure what it really means and when it matters. This article sheds light. |
|
|
|
|
|
End-To-End CNS Drug Development Solutions | e-book | Altasciences | Understand how early engagement with a fully integrated and experienced CNS drug development partner can accelerate timelines by facilitating continuous data sharing and decision-making. |
|
|
|
Spray Drying For Improved Solubility | Q&A | Lonza | In a recent webinar, experts discussed how to develop a spray dried powder formulation and scale it from early feasibility studies to commercial manufacturing. |
|
|
|
|
|
|
|
Peptide Crystallization | Cambrex | Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|